pharma · Asthma · Pharmacokinetics · AMPH
Amphastar France Pharmaceuticals
AMPHASTAR FRANCE PHARMACEUTICALS is a pharma organization headquartered in Rancho Cucamonga, FR. It trades on NYSE under ticker AMPH. Primary therapeutic focus areas include Asthma, Pharmacokinetics, Allergic Skin Reacti
USINE SAINT CHARLES, ERAGNY SUR EPTE, 60590, FR, Rancho Cucamonga HQ
1996 Founded
46 Employees
Public company Type
AMPH · NYSE Ticker
Company details
- Status
- Public
- HQ
- USINE SAINT CHARLES, ERAGNY SUR EPTE, 60590, FR, Rancho Cucamonga
- Founded
- 1996
- Employees
- 46
- Programs
- 18
- Drugs
- 15
- Patents
- 15
Epinephrine (0.125 mg/inhalation)
Approved · other · Pharmacokinetics
Epinephrine (0.125 mg/inhalation) for Pharmacokinetics is a Approved program (other) at Amphastar France Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code API-E004-CL-I
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Amphastar France Pharmaceuticals
- Phase
- Approved
- Modality
- other
- Indication
- Pharmacokinetics
- Status
- completed
- Trials
- 1